Document Detail


[Evaluation of Bone ; Up Date from Research to Clinical Application. Assessment of the treatment of glucocorticoid-induced osteoporosis].
MedLine Citation:
PMID:  23445894     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.
Authors:
Shogo Asano; Atsushi Suzuki
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Clinical calcium     Volume:  23     ISSN:  0917-5857     ISO Abbreviation:  Clin Calcium     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433326     Medline TA:  Clin Calcium     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  401-8     Citation Subset:  IM    
Affiliation:
Toyokawa City Hospital, Toyokawa, Aichi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Evaluation of Bone ; Up Date from Research to Clinical Application. Bone metabolic markers for eval...
Next Document:  [Evaluation of Bone ; Up Date from Research to Clinical Application. Assessment of joint structure i...